Nureca Limited Stock Price Today (NSE: NURECA)

Nureca Limited

338.30+16.10 (+5.00%)
Market Closed

Fundamental Score

...

Nureca Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Nureca Limited share price today is 338.30, up +5.00% on NSE/BSE as of 16 September 2026. Nureca Limited (NURECA) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of 322.81 (Cr). The 52-week high for NURECA share price is 358.00 and the 52-week low is 204.00. At a P/E ratio of 78.67x, NURECA is currently trading above its industry average P/E of 36.70x. 0

Nureca Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
358.00
Low
290.20
Volume
9.8K
Change
-4.83%

Nureca Limited share price chart: -4.83% return over the past month. 52-week high ₹358.00, 52-week low ₹204.00.

Nureca Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
322.20338.30318.00338.3012.35K (Cr)
330.00345.00322.10322.205.71K (Cr)
343.55346.95330.00332.755.81K (Cr)
335.00350.70335.00343.5521.93K (Cr)
316.55334.00316.55334.0012.84K (Cr)
320.00324.90311.00318.103.40K (Cr)
322.70325.00313.10319.202.87K (Cr)
331.90331.90320.10322.705.56K (Cr)
333.00345.55321.25332.604.47K (Cr)
338.05338.05330.30336.751.66K (Cr)

Nureca Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
332.45350.70311.00338.30+1.76%
332.20358.00290.20331.80-0.12%
239.81347.45224.02343.60+43.28%
232.30249.60226.55237.40+2.20%
265.45300.00258.95281.45+6.03%
208.05274.90208.05266.51+28.10%
289.20295.15204.00206.75-28.51%
275.00307.00265.15295.20+7.35%
316.00334.50270.00277.85-12.07%
294.00315.00270.50307.95+4.74%
260.00293.00247.00289.60+11.38%
229.00343.00226.84261.50+14.19%

Returns & Performance

Poor

Return on Equity (ROE)

0.00%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

3.30%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

2.16%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Nureca Limited Valuation Check

Poor

Price to Earnings (P/E)

78.67x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

36.70x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

64.97%

% shares held by company founders/management

Poor

FII Holding

0.28%

% shares held by foreign institutional investors

Poor

DII Holding

0.24%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-100.00%

Net profit growth vs same quarter last year

Good

Revenue Growth (Quarterly YoY)

18.04%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

-7.19%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-49.15%

Earnings per share growth over 5 years

Poor

Net Profit Growth (5-Year CAGR)

-46.15%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.00x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

4.88x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-25.50 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Nureca Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of NURECA across key market metrics for learning purposes.

Positive Indicators

5 factors identified

Strong Revenue Growth (18.04%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Conservative Debt Levels (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Healthy Liquidity Position (Current Ratio: 15.32)

Observation: Strong short-term liquidity to meet obligations.

Analysis: Current ratio >1.5 indicates good working capital management.

Balanced Promoter Holding (64.97%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

11 factors identified

Below-Average Return on Equity (0.00%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (3.30%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Margin Pressure Concerns (2.16%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Premium Valuation Risk (P/E: 78.67x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Profit Decline Concern (-100.00%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Limited Growth History (-7.19% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

Weak Earnings Growth (-49.15% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Stagnant Profit Growth (-46.15% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity.

Negative Free Cash Flow (₹-25.50 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 0.52%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Nureca Limited vs Medical Equipment & Supplies Peers

Peer Comparison - Medical Equipment & Supplies

Compare Nureca Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
16.5/100
338
₹322.81
78.7
Average
0.00%
Poor
3.30%
Poor
0.0
Excellent
-46.15%
Poor
-7.19%
Poor
0.00%
55.6/100
1724
₹17474.36
55.5
Average
10.97%
Average
14.28%
Average
0.1
Excellent
18.85%
Excellent
18.98%
Excellent
0.20%
21.9/100
35
₹2264.62
14.4
Average
8.59%
Poor
11.43%
Average
0.2
Excellent
0.01%
17.1/100
321
₹1709.74
153.8
Average
0.00%
Poor
4.87%
Poor
0.6
Good
-26.20%
Poor
13.04%
Good
0.00%
69.6/100
201
₹1105.47
35.5
Average
12.83%
Average
12.34%
Average
0.0
Excellent
103.10%
Excellent
24.69%
Excellent
0.00%
67.9/100
370
₹782.87
26.8
Average
19.56%
Good
24.40%
Excellent
0.5
Excellent
84.72%
Excellent
38.54%
Excellent
0.00%
64.4/100
468
₹610.20
30.1
Average
18.16%
Good
24.15%
Excellent
0.4
Excellent
68.05%
Excellent
31.02%
Excellent
0.00%
61.5/100
387
₹464.52
20.4
Average
18.60%
Good
23.74%
Excellent
0.0
Excellent
24.33%
Excellent
20.33%
Excellent
0.26%
20.7/100
152
₹293.54
30.8
Average
10.45%
Average
19.30%
Good
0.7
Good
0.45%
38.2/100
103
₹285.51
56.6
Average
7.54%
Poor
12.64%
Average
0.1
Excellent
42.43%
Excellent
16.12%
Excellent
0.00%
32.1/100
150
₹215.42
24.0
Average
11.99%
Average
15.14%
Good
0.0
Excellent
0.00%

Nureca Limited PE Ratio History

Historical price-to-earnings ratio for NURECA — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20250.85₹307.95362.3x
FY 202244.96₹498.1511.1x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Nureca Limited Dividend History

Annual cash dividends paid by NURECA — dividend yield N/A

Financial YearDividends Paid (₹ Cr)
FY 20224.99 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Nureca Limited Quarterly Performance

Latest quarterly metrics for NURECA — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

18.04%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-100.00%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

-7.19%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

-46.15%

Compounded annual net profit growth over 5 years

Nureca Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for NURECA — calculated from daily price history

51RSI 14
Neutral — RSI 51

Momentum is balanced — neither overbought nor oversold.

SMA 50
300
▲ Price above SMA 50 — Short-term bullish
SMA 200
278
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
16K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Nureca Limited Financial Statements

Annual income statement, balance sheet and cash flow for Nureca Limited (NURECA) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Nureca Limited

Loading latest quarterly results...

About NURECA (Nureca Limited)

Nureca Ltd is a dynamic Indian enterprise focused on empowering individuals to proactively manage their health and well-being from the comfort of their homes. They curate and distr...ibute a comprehensive range of medical devices and lifestyle products designed to address both acute and chronic conditions. The company's portfolio encompasses essential diagnostic tools, enabling users to monitor vital signs and track key health indicators. Beyond diagnostics, Nureca offers solutions for pain management, rehabilitation, and overall physical wellness. Their dedication to providing high-quality, user-friendly products reflects a commitment to making healthcare accessible and convenient for all. Nureca's offerings span a wide spectrum of needs, ranging from devices that assist in managing respiratory ailments to innovative gadgets that promote fitness and relaxation. For individuals grappling with chronic conditions, they provide essential tools like blood glucose monitors for diabetes management, and blood pressure monitors for hypertension control. Simultaneously, Nureca caters to the growing interest in preventive healthcare and wellness by offering products such as posture correctors and massagers that aid in musculoskeletal health. This holistic approach underscores their vision of creating a healthier and more informed society. The company strategically positions itself at the intersection of healthcare and technology, integrating connected features into select products to enhance user experience and data tracking. By seamlessly blending traditional medical devices with modern connectivity, Nureca strives to provide consumers with a comprehensive and integrated approach to healthcare management. Their dedication to product quality, coupled with their commitment to innovation and customer satisfaction, solidifies Nureca's position as a leader in the rapidly evolving home healthcare market in India.

Company Details

Symbol:NURECA
Industry:Medical Equipment & Supplies
Sector:Medical Equipment & Supplies

Key Leadership

Mr. Saurabh Goyal
Co-Founder, MD & Chairman
Mr. Aryan Goyal
Co-Founder, CEO & Whole-time Director
Mr. Rajinder Sharma
Whole-Time Director

NURECA Share Price: Frequently Asked Questions

What is the current share price of Nureca Limited?

Nureca Limited (NURECA) trades at ₹338.30 on NSE and BSE. Market cap ₹322.81 (Cr). Educational data only.

What is the P/E ratio of Nureca Limited?

Nureca Limited has a P/E of 78.67x vs industry average 36.70x.

What is the Bull Run score for Nureca Limited?

Nureca Limited has a Bull Run score of 16.5/100 based on 25+ financial parameters.

Does Nureca Limited pay dividends?

Nureca Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Nureca Limited?

Nureca Limited has ROE of 0.00%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Nureca Limited?

Nureca Limited has debt-to-equity of 0.00.

Is Nureca Limited a good investment?

Bull Run gives Nureca Limited a score of 16.5/100. This is not investment advice — consult a SEBI-registered advisor.